Our Story

Behind 3D BioAnalytiX stand more than five decades of excellence in proteomics research and development and a huge passion for science.

Sandra Pankow, Ph.D.

Founder & CEO

I have always enjoyed being at the forefront of proteomics as a scientist in the laboratory of Prof. Dr. John R. Yates at The Scripps Research Institute, California. I am particularly passionate about developing novel proteomics methods that will lead to better treatment of devastating misfolding diseases such as Alzheimer's, dementia and related neurodegenerative diseases. By founding 3D BioAnalytiX I decided to pour this passion into developing actual products that can accelerate drug development and transform diagnosis and therapy of these diseases. Therefore, we provide innovative tools to help you advance your drug development and structural proteomics research and develop better diagnostic tests to help find cures for devastating diseases faster. Together, we can create better medicines for a better tomorrow.